These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 429876)

  • 1. Effects of dialyzable leukocyte extracts with transfer factor activity on leukocyte migration in vitro. 1. Antigen-dependent inhibition and antigen-independent inhibition and enhancement of migration.
    Wilson GB; Fudenberg HH; Horsmanheimo M
    J Lab Clin Med; 1979 May; 93(5):800-18. PubMed ID: 429876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of dialyzable leukocyte extracts with transfer factor activity on leukocyte migration in vitro. II. Separation and partial characterization of the components in DLE producing antigen-dependent and antigen-independent effects.
    Wilson GB; Fudenberg HH
    J Lab Clin Med; 1979 May; 93(5):819-37. PubMed ID: 429877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies of an assay system for dialyzable leukocyte extracts (DLE)--influence of DLE on leukocyte migration inhibition test by HBsAg].
    Hashimoto Y; Sekiguchi S
    Hokkaido Igaku Zasshi; 1985 Sep; 60(5):763-8. PubMed ID: 3908264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen-specific activity of murine leukocyte dialysates containing transfer factor on human leukocytes in the leukocyte migration inhibition (LMI) assay.
    Borkowsky W; Suleski P; Bhardwaj N; Lawrence HS
    J Immunol; 1981 Jan; 126(1):80-2. PubMed ID: 6161170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct components in dialyzable leukocyte extracts (DLE) have specific and nonspecific effects on cellular immunity as shown by leukocyte migration inhibition.
    Wilson GB; Fudenberg HH; Bahm VJ
    Trans Assoc Am Physicians; 1978; 91():295-332. PubMed ID: 754397
    [No Abstract]   [Full Text] [Related]  

  • 6. Human cell-mediated immunity to tuberculin as assayed by the agarose micro-droplet leukocyte migration inhibition technique: comparison with the capillary tube assay.
    McCoy JL; Dean JH; Herberman RB
    J Immunol Methods; 1977; 15(4):355-71. PubMed ID: 874326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for immunotherapy of antigen-specific defects with transfer factor.
    Wilson GB; Fudenberg HH; Keller RH
    J Clin Lab Immunol; 1984 Feb; 13(2):51-8. PubMed ID: 6202873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dialyzable leukocyte extracts with transfer factor activity on leukocyte migration in vitro. V. Antigen-specific lymphocyte responsiveness can be initiated by two structurally distinct polyribonucleopeptides.
    Wilson GB; Paddock GV; Fudenberg HH
    Thymus; 1981 Feb; 2(4-5):257-6. PubMed ID: 6165106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-mediated immunity: correlation of mixed-leucocyte-macrophage migration inhibition with delayed-type hypersensitivity after immunization and donor-specific transfer of cell migration inhibition by dialyzable leucocyte extract.
    Mazaheri R; Hamblin AS; Zuckerman AJ
    Cell Immunol; 1983 Nov; 82(1):147-62. PubMed ID: 6196129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dialyzable leukocyte extracts (DLEs) with transfer factor activity on leukocyte migration in vitro. III. Characterization of the antigen-independent migration inhibition factor in DLEs as a neutrophil immobilizing factor.
    Wilson GB; Smith CL; Fudenberg HH
    J Allergy Clin Immunol; 1979 Jul; 64(1):56-66. PubMed ID: 447952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dialyzable leukocyte extracts (DLE) with transfer factor activity on leukocyte migration in vitro. IV. Two distinct effects of DLE on leukocyte migration can be produced by prostaglandins.
    Wilson GB; Fudenberg HH; Jonsson HT; Smith CL
    Clin Immunol Immunopathol; 1980 May; 16(1):90-102. PubMed ID: 7379353
    [No Abstract]   [Full Text] [Related]  

  • 12. Transfer of osteosarcoma-specific cell-mediated immunity in hamsters by rabbit dialyzable leukocyte extracts.
    Tsang KY; Fudenberg HH; Pan JF
    Cell Immunol; 1985 Feb; 90(2):295-302. PubMed ID: 3855389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Counter inhibitor: a low molecular weight cytokine derived from human leukocyte dialysates reverses antigen dependent PMN and macrophage migration inhibition.
    Farmer JL; Rosenberg JS; Hester RB; Gottlieb AA
    Int Arch Allergy Appl Immunol; 1984; 73(2):146-50. PubMed ID: 6363305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An animal model for evaluation of antigen-specific dialyzable leukocyte extracts therapy of osteosarcoma.
    Tsang KY; Pan JF; Fudenberg HH
    Clin Immunol Immunopathol; 1987 Mar; 42(3):360-9. PubMed ID: 3470162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the immunopotentiator effects of dialyzable leukocyte extracts obtained out of leukocytes previously used for interferon production.
    Arala-Chaves MP; Porto MT; Kauppinen HL; Massa AA; Myllylä G
    Vox Sang; 1982 Nov; 43(5):233-42. PubMed ID: 6183830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of PPD and BCG-induced leukocyte migration inhibition, delayed cutaneous hypersensitivity, lymphocyte transformation in vitro and humoral antibodies to PPD in man.
    Fleer A; van der Hart M; Blok-Schut BJ; Schellekens PT
    Eur J Immunol; 1976 Mar; 6(3):163-7. PubMed ID: 791653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmentation of delayed-type hypersensitivity in antigen-primed guinea pigs by human dialyzable leukocyte extract. Chromatographic and enzymatic characterization of the active principle.
    Ashorn RG; Marnela KM; Uotila A; Krohn KJ
    Acta Pathol Microbiol Immunol Scand C; 1982 Dec; 90(6):331-7. PubMed ID: 6763449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New and cost effective cell-based assay for Dialyzed Leukocyte Extract (DLE)-induced Jurkat cells proliferation under azathioprine treatment.
    Cardoso FM; Tomkova M; Petrovajova D; Bubanova M; Ragac O; Hornakova T
    J Pharm Biomed Anal; 2017 May; 138():100-108. PubMed ID: 28189890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Migration inhibition of T lymphocytes from human peripheral blood by specific antigen and lymphokines.
    Kowalczyk D; Zembala M
    Clin Exp Immunol; 1978 May; 32(2):333-8. PubMed ID: 307468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dialyzed leukocyte extracts for the treatment of recurrent and severe infections in pediatric patients with cellular immunodeficiency: 15 years of experience].
    Ayala MC; González NM; Palacios G; Rivera-Morales LG; Rodríguez-Padilla C
    Rev Alerg Mex; 2019; 66(1):27-37. PubMed ID: 31013404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.